Skip to main content
. 2019 Dec;8(8):2680–2690. doi: 10.21037/tcr.2019.10.27

Table 3. Association of prechemotherapy tumor markers with response to chemotherapy.

Tumor marker N Response [n (%)] P value
Clinical benefit Non-clinical benefit
CEA 0.415
   − 43 32 (74.4) 11 (25.6)
   + 38 31 (78.9) 7 (21.1)
CA199 0.027
   − 46 31 (67.4) 15 (32.6)
   + 34 30 (88.2) 4 (11.8)
CA72.4 0.195
   − 33 23 (69.7) 10 (30.3)
   + 42 34 (81.0) 8 (19.0)
CA125 0.428
   − 44 32 (72.7) 12 (27.3)
   + 27 21 (77.8) 6 (22.2)